Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Series A

AavantiBio activates with $107m
Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.
Daily deal net: October 16, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ori derives $30m series A
Five years after being co-founded by UCL researchers, Ori Biotech has brought its overall funding to $41m.
UPMC crosses Abridge for $15m
Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.
Walden Biosciences welcomes $51m
Kidney disease-focused drug developer Walden was co-founded by faculty members of Rush University and Harvard University earlier this year.
UpShow entertains $14m series A
4490 Ventures, a VC firm aligned to University of Wisconsin-Madison, backed a series A extension intended to advance in-venue digital marketing technology company UpShow's product and recruitment plans.
Polyneuron binds in extra series A cash
HBM Healthcare chipped in additional funding to bring University of Basel spinout Polyneuron's series A round to $39.7m.
Daily deal net: September 22, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Other News

Daily deal net: September 21, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Space Pioneer opens airlock for series A funding
A Zhejiang University subsidiary has supplied funding to space tech startup Space Pioneer, which has raised at least $29.6m in six months.
Daily deal net: September 17, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Graphite Bio fleshes out $45m series A
Graphite Bio's first drug program will target sickle cell anaemia based on innovations in DNA editing from Stanford University.
Daily deal net: September 15, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Syncona settles Resolution with $34.5m series A
Syncona has equipped Resolution with funding to explore a restorative liver therapy based on the research of Edinburgh's Prof Stuart Forbes.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
Sphere Fluidics circles $2.5m
test reg

Login